贝因美股份有限公司 独立董事关于公司第八届董事会第二十四次会议 相关事项的独立意见 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准则》 及《深圳证券交易所股票上市规则》《深圳证券交易所上市公司规范运作指引》等 相关法律法规、规范性文件和《贝因美股份有限公司章程》的规定，我们作为贝因 美股份有限公司（以下简称"公司"）的独立董事，本着实事求是、认真负责的态 度，公平、公正、诚实信用的原则，基于独立判断的立场，现对公司第八届董事会 第二十四次会议审议的议案进行了认真审核，并发表独立意见如下： 1、关于实施第四期员工持股计划的独立意见 我们认真审阅了公司《关于<贝因美股份有限公司第四期员工持股计划（草 案）>及其摘要的议案》和《第四期员工持股计划管理办法》，认为（1）公司员工 持股计划的内容符合《关于上市公司实施员工持股计划试点的指导意见》《公司章 程》等有关法律、法规的规定，不存在损害公司及全体股东特别是中小股东利益的 情形，亦不存在摊派、强行分配等方式强制员工参与本次员工持股计划的情形；（2） 公司实施员工持股计划有利于完善公司激励机制，充分调动员工积极性，实现企业 价值、股东回报与员工利 ...

第二期股票期权激励计划预留股票期权激励对象名单 | 序号 | 姓名 | 职务 | | --- | --- | --- | | 1 | 刘飞 | 业务骨干 | | 2 | 金丽施 | 业务骨干 | | 3 | 莫红悦 | 业务骨干 | | 4 | 沈钱忠 | 业务骨干 | | 5 | 周鹏飞 | 业务骨干 | | 6 | 郭志远 | 业务骨干 | | 7 | 胡婧媛 | 业务骨干 | | 8 | 杨爽 | 业务骨干 | | 9 | 张潇艳 | 业务骨干 | | 10 | 黄黎明 | 业务骨干 | | 11 | 方苏玉 | 业务骨干 | | 12 | 翁凌飞 | 业务骨干 | | 13 | 张立松 | 业务骨干 | | 14 | 张积良 | 业务骨干 | | 15 | 宋成 | 业务骨干 | | 16 | 马洪旭 | 业务骨干 | | 17 | 薛淑亮 | 业务骨干 | | 18 | 刘仁宝 | 业务骨干 | 贝因美股份有限公司 一、激励对象获授的股票期权分配情况 | 职务 | 获授的股票期权 | 占授予股票期 | 占公司目前 | | --- | --- | --- | --- | | | 数量（万份） | 权总 ...

证券代码：002570 证券简称：贝因美 公告编号：2023-060 贝因美股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 贝因美股份有限公司（以下简称"公司"）于 2023 年 8 月 11 日召开第八届 董事会第二十四次会议，审议通过了《关于第二期股票期权激励计划向激励对象 授予预留股票期权的议案》，同意向符合条件的 38 名激励对象授予第二期股票期 权激励计划的预留期权，合计 487.94 万份，授予日为 2023 年 8 月 11 日。现将 有关事项公告如下： 一、第二期股票期权激励计划简述及已履行的决策程序 （一）第二期股票期权激励计划简述 公司《第二期股票期权激励计划》已经 2022 年第二次临时股东大会审议通 过，主要内容如下： 1、激励形式：本次激励计划所采用的激励形式为股票期权。 2、标的股票来源：贝因美股份有限公司回购专户中的本公司人民币普通股 （A 股）股票和/或向激励对象定向发行的公司 A 股普通股股票。 3、激励对象：符合激励资格的业务骨干及特别贡献人员，包括 SBU 业务负 责人、BU 业务负责人、省区业务负责人、城市 ...

2、关于向激励对象授予第二期股票期权激励计划预留股票期权的书面审核 意见 根据《上市公司治理准则》《深圳证券交易所股票上市规则》及《深圳证券 交易所上市公司规范运作指引》等相关法律法规、规范性文件和《公司章程》《监 事会议事规则》的规定，我们作为贝因美股份有限公司（以下简称"公司"）的 监事，本着实事求是、认真负责的态度，公平、公正、诚实信用的原则，对公司 第八届监事会第十四次会议审议的相关事项进行了认真审核，并发表审核意见如 下： 1、关于《贝因美股份有限公司第四期员工持股计划（草案）》及其摘要的 书面审核意见 经审核，我们认为：公司董事会提出的《关于<贝因美股份有限公司第四期 员工持股计划（草案）>及其摘要的议案》的内容符合《公司法》《证券法》《关 于上市公司实施员工持股计划试点的指导意见》等有关法律、法规及规范性文件 的规定，本次审议员工持股计划相关议案的程序和决策合法、有效，不存在损害 公司及全体股东利益的情形，亦不存在摊派、强行分配等方式强制员工参与本次 员工持股计划的情形，有利于公司的持续发展。 综上所述，我们一致同意公司实施本次员工持股计划。 贝因美股份有限公司 关于公司第八届监事会第十四次会议 ...

贝因美股份有限公司董事会 三、本员工持股计划遵循公司自主决定、员工自愿参加的原则。公司实施员 工持股计划前，通过职工代表大会等组织充分征求员工意见，不存在以摊派、强 行分配等方式强制员工参加的情形。 四、本员工持股计划拟定的持有人名单均符合《指导意见》《自律监管指引 第 1 号》等相关法律、法规规定的持有人条件，符合本员工持股计划规定的持有 人范围，其作为公司本员工持股计划持有人的主体资格合法、有效。 五、关联董事已根据《指导意见》《自律监管指引第 1 号》等有关法律、法 规和规范性文件以及《公司章程》的规定对相关议案回避表决，由非关联董事审 议表决，公司审议本员工持股计划相关议案的决策程序合法、有效。 六、公司实施本员工持股计划有利于充分调动员工的积极性和创造力，进一 步提升公司治理水平，凝聚核心团队的同时提高公司核心竞争力，实现公司的长 期、持续和健康发展。 特此说明。 贝因美股份有限公司董事会 关于第四期员工持股计划（草案）的合规性说明 贝因美股份有限公司（以下简称"公司"）根据《中华人民共和国公司法》 （以下简称"《公司法》"）《中华人民共和国证券法》（以下简称"《证券法》"）《深 圳证券交易所上市公 ...

贝因美股份有限公司第四期员工持股计划（草案）摘要 证券代码：002570 证券简称：贝因美 公告编号：2023-059 贝因美股份有限公司 第四期员工持股计划（草案） 摘要 二〇二三年八月 1 贝因美股份有限公司第四期员工持股计划（草案）摘要 声明 本公司及董事会全体成员保证本员工持股计划内容真实、准确和完整，不存 在虚假记载、误导性陈述或重大遗漏。 2 贝因美股份有限公司第四期员工持股计划（草案）摘要 风险提示 1、贝因美股份有限公司（以下简称"公司"）第四期员工持股计划须经公司 股东大会批准后方可实施，本次员工持股计划能否获得公司股东大会批准，存在 不确定性。 2、本员工持股计划设立后将由公司自行管理，但能否达到计划规模、目标 存在不确定性。 3、有关本员工持股计划具体的资金来源、出资金额、实施方案等属初步结 果，能否完成实施，存在不确定性。 4、若员工认购资金较低时，本员工持股计划存在无法成立的风险。 5、股票价格受公司经营业绩、宏观经济周期、国际/国内政治经济形势及投 资者心理等多种复杂因素影响。因此，股票交易是有一定风险的投资活动，投资 者对此应有充分准备。 6、敬请广大投资者谨慎决策，注意投资风险 ...

本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流。活动时间为 2023 年 5 月 12 日（周五）15:00-17:00。届时公司 董事长兼总经理谢宏先生、独立董事胡军辉先生、财务总监金志强先生、董事会 秘书李志容女士（如遇特殊情况，参会人员将有调整）将在线就公司 2022 年度 业绩、公司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等投 资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 为提高互动交流的效率，现提前向所有关心公司的投资者公开征集交流问题， 广泛听取投资者的意见和建议。投资者可于 2023 年 5 月 11 日（星期四）17:00 前访问 http://ir.p5w.net/zj/，或扫描下方二维码，进入问题征集专题页面，提交您 所关心的问题。 （互动交流问题征集专题页面二维码） 特此公告。 贝因美股份有限公司 关于参加浙江辖区上市公司 2023 年投资者网上集体接待日活动 暨 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信 ...

证券代码：002570 证券简称：贝因美 公告编号：2023-044 关于参加浙江辖区上市公司 2023 年投资者网上集体接待日活动 贝因美股份有限公司 暨 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 贝因美股份有限公司（以下简称"公司"）2022 年年度报告已于 2023 年 4 月 29 日披露，为进一步加强与投资者的互动交流，公司将参加由浙江证监局、 浙江省上市公司协会与深圳市全景网络有限公司联合举办的"2023 年浙江辖区 上市公司投资者集体接待日活动"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流。活动时间为 2023 年 5 月 12 日（周五）15:00-17:00。届时公司 董事长兼总经理谢宏先生、独立董事胡军辉先生、财务总监金志强先生、董事会 秘书李志容女士（如遇特殊情况，参会人员将有调整）将在线就公司 2022 年度 业绩、公司治理、发展战略、经营状况 ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥1,399,938,197.45, representing a 24.83% increase compared to ¥1,121,481,666.83 in the same period last year[24]. - The net profit attributable to shareholders of the listed company was ¥42,914,990.66, up 28.01% from ¥33,524,658.31 in the previous year[24]. - The net profit after deducting non-recurring gains and losses increased by 60.08%, reaching ¥27,356,468.67 compared to ¥17,088,924.55 in the same period last year[24]. - The net cash flow from operating activities surged by 412.18%, amounting to ¥186,103,264.43, compared to ¥36,335,620.30 in the previous year[24]. - Basic earnings per share rose to ¥0.04, a 33.33% increase from ¥0.03 in the same period last year[24]. - Total revenue for the reporting period reached ¥1,399,938,197.45, representing a year-on-year increase of 24.83% compared to ¥1,121,481,666.83 in the same period last year[58]. - The company reported a total comprehensive income for the first half of 2022 of CNY 43,719,463.40, which includes a net profit of CNY 42,914,990.66[186]. - The total comprehensive income for the first half of 2022 was CNY 40,962,410.80, reflecting an increase of 2,896,946.15 compared to the previous period[190]. Assets and Liabilities - Total assets at the end of the reporting period were ¥4,079,980,580.69, reflecting a 0.26% increase from ¥4,069,421,166.85 at the end of the previous year[24]. - The total assets as of June 30, 2022, amounted to ¥4,785,689,523.06, compared to ¥4,612,473,272.99 at the beginning of the year, indicating an increase of 3.8%[166]. - The total liabilities as of June 30, 2022, were ¥2,669,442,398.12, up from ¥2,519,631,052.61 at the start of the year, representing a growth of 5.9%[166]. - The company's total liabilities were CNY 1,022,520,000.00, reflecting a significant portion of the total assets[194]. - The company's cash and cash equivalents at the end of the reporting period were CNY 253,993,951.66, which is crucial for liquidity management[194]. Revenue Breakdown - Revenue from milk powder products was ¥1,190,471,160.39, accounting for 85.04% of total revenue, with an 18.20% increase from ¥1,007,187,511.03[59]. - The sales revenue of children's powder increased by 286% year-on-year, while the sales of special medical formula milk powder grew by over 62.40%[37]. - The gross profit margin for the main business was 48.55%, with a year-on-year revenue change of 16.44%[41]. - The gross profit margin for the infant industry was 43.85%, down 9.75% from the previous year, with costs rising by 51.07%[60]. Investments and R&D - The company holds 21 invention patents and has registered 60 infant formula products, showcasing its strong R&D capabilities[48]. - Research and development expenses decreased by 28.95% to ¥10,698,461.48 from ¥15,058,142.75 in the previous year[55]. - The company is actively exploring precise nutrition formula products and other related services to address the risk of declining newborn population[86]. - The company has initiated research and development efforts for new technologies aimed at improving operational efficiency[191]. Shareholder and Equity Information - The total number of ordinary shareholders at the end of the reporting period was 74,300[146]. - The company’s major shareholder, Beiyinmei Group, reduced its holdings by 10.8 million shares, representing 0.9999% of the total share capital, and currently holds 201,418,500 shares, or 18.65%[140]. - The total equity attributable to shareholders at the end of the reporting period was CNY 1,536,709,519.15, with a decrease of CNY 980,002,691.94 from the beginning of the year[194]. - The retained earnings at the end of the period were CNY -532,275,686.03, indicating accumulated losses[199]. Operational Highlights - The company has established a new retail business model that integrates online and offline sales channels[40]. - The number of distributors increased from 1,526 at the end of 2021 to 1,685 by June 2022, marking a 10% growth[42]. - The company has committed to using raised funds according to regulatory requirements and its own distribution plan[79]. - The company is implementing effective supply chain management to mitigate related risks and ensure inventory control[87]. Compliance and Governance - The company emphasizes the importance of regulatory compliance and has urged subsidiaries to enhance operational standards to prevent similar investment issues in the future[134]. - The company is focused on maintaining compliance with environmental regulations and has established a comprehensive environmental management system[98]. - The company has not reported any changes in the use of raised funds or any issues in their disclosure[80]. Social Responsibility - The company donated 294 boxes of infant nutrition products valued at over 310,000 yuan to the Shanghai Fosun Public Welfare Foundation during the reporting period[99].

Financial Performance - The company's operating revenue for Q1 2023 was ¥717,274,967.43, a decrease of 3.04% compared to ¥814,448,112.17 in the same period last year[3]. - The net profit attributable to shareholders decreased by 39.13% to ¥12,250,864.35 from ¥20,126,374.67 year-on-year[3]. - The net profit after deducting non-recurring gains and losses dropped by 74.40% to ¥3,972,825.65 compared to ¥15,517,744.73 in the previous year[3]. - The total operating revenue for the first quarter of 2023 was CNY 717,274,967.43, an increase from CNY 696,112,450.13 in the same period last year, representing a growth of approximately 1.67%[26]. - The net profit for the first quarter of 2023 was CNY 13,837,189.83, a decrease from CNY 20,984,457.67 in the previous year, reflecting a decline of approximately 34%[26]. - The net profit attributable to the parent company for Q1 2023 was CNY 12,250,864.35, a decrease from CNY 20,126,374.67 in the same period last year, representing a decline of approximately 39.1%[27]. - The total comprehensive income attributable to the parent company was CNY 17,024,071.02, compared to CNY 16,283,924.71 in the previous year, showing an increase of about 4.5%[27]. Cash Flow - The net cash flow from operating activities decreased by 55.10% to ¥23,750,966.73 from ¥52,895,828.43 year-on-year[3]. - The company reported a significant decrease in cash received from operating activities, down 63.26% to ¥1,804.05 million, mainly due to reduced recoveries of operating deposits[11]. - Cash inflows from operating activities totaled CNY 752,979,771.67, up from CNY 709,547,323.73 year-over-year, indicating a growth of approximately 6.1%[30]. - The net cash flow from operating activities decreased to CNY 23,750,966.73 from CNY 52,895,828.43, reflecting a decline of about 55.8%[30]. - The cash flow from financing activities decreased by 84.5% to ¥38,601.96 million, primarily due to reduced bank borrowings compared to the previous year[12]. - The net cash flow from financing activities was negative at CNY -26,579,720.89, compared to CNY -31,319,485.85 in the previous year, showing an improvement of about 15.5%[31]. - Cash outflows from investing activities amounted to CNY 29,791,043.11, down from CNY 57,858,101.19, a reduction of approximately 48.6%[30]. Assets and Liabilities - The total assets at the end of the reporting period increased by 0.54% to ¥3,898,115,578.61 from ¥3,877,108,863.41 at the end of the previous year[3]. - The company's total assets as of March 31, 2023, amounted to CNY 3,898,115,578.61, compared to CNY 3,877,108,863.41 at the beginning of the year, showing a slight increase of about 0.54%[24]. - The total liabilities increased to CNY 2,304,620,657.89 from CNY 2,285,997,270.56, marking an increase of approximately 0.76%[24]. Shareholder Information - Total number of ordinary shareholders at the end of the reporting period was 75,946[15]. - The largest shareholder, Beiyinmei Group Co., Ltd., holds 18.19% of shares, totaling 196,418,500 shares, with 194,850,000 shares pledged[15]. - The company repurchased 28,412,298 shares, accounting for 2.63% of the total share capital[16]. Corporate Actions and Developments - The company plans to support the establishment of an industrial incubation fund by its wholly-owned subsidiary to enhance investment risk management[17]. - A proposal to establish a wholly-owned subsidiary in Taizhou with a registered capital of RMB 1 million was approved, but registration has been suspended due to business development adjustments[18]. - The company has completed the deregistration of five subsidiaries as part of its business development needs[19]. - The company is currently undergoing legal proceedings involving a claim of RMB 316.05 million and associated interest[19]. Financial Ratios and Metrics - The weighted average return on equity decreased by 0.33% to 0.79% compared to 1.12% in the same period last year[3]. - The company's inventory as of March 31, 2023, was CNY 405,260,935.46, slightly down from CNY 413,034,354.70 at the start of the year, indicating a decrease of approximately 1.84%[22]. - The company's capital reserve increased to CNY 1,446,574,558.13 from CNY 1,444,524,472.76, showing a growth of about 0.14%[24]. - The company’s total equity as of March 31, 2023, was CNY 1,593,494,920.72, a slight increase from CNY 1,591,111,592.85 at the beginning of the year, representing a growth of approximately 0.15%[24]. - The company reported a basic and diluted earnings per share of CNY 0.01, down from CNY 0.02 in the same quarter last year[27]. Financial Expenses - Financial expenses increased by 258.31% to ¥1,100.95 million due to higher exchange losses compared to the same period last year[9]. - The company reported a financial expense of CNY 15,271,516.92 for the first quarter, which is significantly higher than CNY 4,262,045.77 in the previous year, reflecting an increase of approximately 258%[26]. Tax and Refunds - The company received CNY 45,947.89 in tax refunds, significantly lower than CNY 1,717,432.60 received in the previous year[30]. Audit and Mergers - The company did not conduct any mergers or acquisitions during the reporting period, and the report was not audited[32].